Holen Sie sich die Stockscreener-App
140.41
1.58%
2.19
Vorhandelsmarkt:
139.66
-0.75
-0.53%
Schlusskurs vom Vortag:
$138.22
Offen:
$139.2
24-Stunden-Volumen:
1.83M
Relative Volume:
1.13
Marktkapitalisierung:
$9.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.40%
1M Leistung:
+5.54%
6M Leistung:
+2.47%
1J Leistung:
-5.24%
1-Tages-Spanne:
$139.03
$141.10
1-Wochen-Bereich:
$137.63
$141.10
52-Wochen-Spanne:
$107.43
$150.56
Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
Ishares Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IBB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBB
Ishares Biotechnology Etf
|
140.41 | 9.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
315.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
640.27 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
643.42 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
251.20 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
565.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Healthcare Stocks Move In Different Directions On Key News - Finimize
Bio-Techne Stock: Analyst Estimates & Ratings - NewsBreak: Local News & Alerts
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
The Longevity Dividend: How Financial Institutions Are Pioneering the Future of Retirement and Healthspan Investing - AInvest
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Solar, biotech, and health insurance stocks are moving on Friday: here's why - TheStreet
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
ARKK Inflows Stay Hot - ETF.com
7 Best Biotech ETFs to Buy Now - US News Money
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
The Silver Dividend: Unlocking Longevity-Driven Investment Opportunities in Healthspan, AI, and Age-Friendly Infrastructure - AInvest
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
The Silver Dividend: Strategic Investments in Longevity Technologies and Age-Friendly Sectors for 2025 and Beyond - AInvest
The Longevity Dividend: Investing in the Future of Healthspan Extension - AInvest
Unlocking the Longevity Dividend: Growth Stocks for the Age of Extended Lifespans - AInvest
BIO assets in stake since beginning, accumulating XP for token launch with $205,000 FDV. - AInvest
The Silver Dividend: How Aging Populations Can Drive Economic Growth and Longevity-Linked Investment Opportunities - AInvest
The Silent Crisis: Aging Populations and the Retirement Security Imperative - AInvest
💸 Is there any unusual option activity or capital flow in tech ETFs? - AInvest
Vertex Pharmaceuticals Plunges 2.69%—Is This the Bottom for Vertex Pharmaceuticals? - AInvest
Health Care Stocks Slipped As Big Players Disappointed - Finimize
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday - 富途牛牛
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Vertex Pharmaceuticals Plunges 19.23%—What Storm is Brewing in Biotech? - AInvest
State-Level Innovation Resilience in a Federal Funding Vacuum - AInvest
The Longevity Dividend: Unlocking AgeTech's Potential in a World of Extended Healthspans - AInvest
The Longevity Dividend: Unlocking Investment Opportunities in an Aging World - AInvest
Health Care Stocks Take A Tumble Across The Board - Finimize
RSG Q3 EPS Forecast Lowered by National Bank Financial - Defense World
William Blair Issues Positive Outlook for SOFI Earnings - Defense World
Sen. Markwayne Mullin Purchases Shares of Zoetis Inc. (NYSE:ZTS) - Defense World
Aurora Innovation (NASDAQ:AUR) Shares Gap Up on Strong Earnings - Defense World
Rep. Robert Bresnahan, Jr. Buys JPMorgan Chase & Co. (NYSE:JPM) Stock - Defense World
Atb Cap Markets Has Negative Estimate for NOV Q3 Earnings - Defense World
LPL Financial (NASDAQ:LPLA) Shares Acquired Sen. Markwayne Mullin - Defense World
Royal Bank Of Canada Lowers NOV (NYSE:NOV) Price Target to $18.00 - Defense World
B. Riley Reaffirms “Buy” Rating for Booking (NASDAQ:BKNG) - Defense World
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Raised to Neutral at JPMorgan Chase & Co. - Defense World
Susquehanna Boosts Boeing (NYSE:BA) Price Target to $270.00 - Defense World
Q3 EPS Estimates for Montauk Renewables Reduced by B. Riley - Defense World
Reckitt Benckiser Group plc (LON:RKT) Insider Tamara Ingram Purchases 293 Shares of Stock - Defense World
Celestica (NYSE:CLS) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Q3 EPS Estimates for WM Raised by National Bank Financial - Defense World
Truist Financial Boosts Sensata Technologies (NYSE:ST) Price Target to $35.00 - Defense World
Vestcor Inc Reduces Position in National Health Investors, Inc. (NYSE:NHI) - Defense World
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):